ACEI/ARB therapy for aortic stenosis

September 2011
Travel Medicine Advisor;Sep2011 Supplement, p1
The article offers information on the study which suggests that angiotensin converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are inadvisable for patients with aortic stenosis.


Related Articles

  • ACEI/ARB therapy for aortic stenosis.  // OB/GYN Clinical Alert;Sep2011 Pharmacology Watch, p1 

    The article discusses an observational study conducted in Scotland which concluded that angiotensin receptor blockers (ARBs) and angiotensin converting enzyme inhibitors (ACEIs) therapy is linked with increase survival and lower risk of cardiovascular (CV) events in patient with aortic stenosis...

  • ACE Inhibitors/ARBs for Aortic Stenosis? Boyle, Andrew J. // Internal Medicine Alert;10/29/2011, Vol. 33 Issue 20, p156 

    An abstract related to a research conducted on examining whether the use of angiotensin converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) is beneficial in patients with aortic stenosis (AS), is presented.

  • ACEI/ARB therapy for aortic stenosis.  // Infectious Disease Alert;Sep2011 Clinical Bri, p1 

    The article discusses a study which revealed that drugs, such as angiotensin converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), which block the renin-angiotensin system are associated with improved survival and lower risk of cardiovascular events in patients with...

  • Some disagreement over which heart attack patients should get ACE inhibitors.  // Modern Medicine;Nov94, Vol. 62 Issue 11, p16 

    Reports on the disagreement by speakers at a joint meeting of the World Congress of Cardiology and European Society of Cardiology in Berlin over which heart attack patient should get angiotensin-converting enzyme (ACE) inhibitors. GSS-3 study; ISIS-4 trial; Acute Infarction Ramipril Efficacy...

  • ACE inhibitor for hypertension.  // Modern Medicine;Aug95, Vol. 63 Issue 8, p26 

    Reports that the angiotensin-converting enzyme (ACE) inhibitor moexipril HCL has been approved for treating hypertension. Suggested starting dosage; Contraindications; Side effects.

  • Review: Concomitant aspirin use does not reduce the effectiveness of ACE inhibitors. Teo, K.K.; Yusuf, S.; Pfeffer, M.; Cohn, Jay N. // ACP Journal Club;May/Jun2003, Vol. 138 Issue 3, p64 

    Summarizes a study that determined whether concomitant use of aspirin reduces the effectiveness of angiotensin-converting enzyme (ACE) inhibitor treatment. Source of the information used in the study; Main results of the study; Significance of aspirin and ACE inhibitors.

  • Insufficient Monitoring with ACE Inhibitors Is a Preventable Cause of Uremia.  // Kidney;Nov/Dec99, Vol. 8 Issue 6, p266 

    Reports on the measurement of the current pattern of use of angiotensin converting enzyme (ACE) inhibitors as well as the monitoring practices of renal function by general practitioners and the frequency of admissions for uremia related to the use of ACE inhibitors. Reason for late detection of...

  • Iron Supplements May Stop Drug-Induced Cough. Napoli, Maryann // HealthFacts;Sep2001, Vol. 26 Issue 9, p4 

    Presents the result of a study by Sang-Choi Lee and colleagues on the therapeutic use of iron supplements in persistent dry cough suffered by people who are on angiotensin converting enzyme inhibitors.

  • Support is substantial for routinely prescribing ACE inhibitors for CHF.  // Modern Medicine;Aug95, Vol. 63 Issue 8, p45 

    Presents an abstract of the study titled `Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure', by R. Garg and S. Yusus, published in the May 10, 1995 issue of `Journal of the American Medical Association.'


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics